OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

PHILLIPS 66 DL-,01/  US7185461040  /

Düsseldorf
2024-08-09  7:30:03 PM Chg. +0.76 Volume Bid8:04:51 PM Ask8:04:51 PM Market Capitalization Dividend Y. P/E Ratio
124.60EUR +0.61% 0
Turnover: 0.00		 123.78Bid Size: 70 124.26Ask Size: 70 53.34 bill.EUR - -
Newsfile Corp 07-04 King Fuels Announces Expansion Across the U.S.
GlobeNewswire 07-01 Phillips Edison & Company Announces Appointment of Devin Murphy to Board of Directors
GlobeNewswire 06-27 Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Inte...
GlobeNewswire 06-26 Almaden Announces Results of Annual General Meeting
GlobeNewswire 06-25 FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technolog...
GlobeNewswire 06-21 Lifetime Brands, Inc. Announces Results of 2024 Annual Meeting
GlobeNewswire 06-20 The International Food Information Council (IFIC) Releases Annual Food & Health Survey Revealing Ris...
GlobeNewswire 06-18 EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
GlobeNewswire 06-17 Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call
GlobeNewswire 06-17 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 06-13 Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
GlobeNewswire 06-13 FibroBiologics Set to Join Russell 2000® Index
GlobeNewswire 06-12 Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...
GlobeNewswire 06-06 FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
GlobeNewswire 06-05 EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire 05-30 Celebrate Life’s Sweet Surprises in New Children’s Book THE ICE CREAM TREE
GlobeNewswire 05-29 Phillips Edison & Company to Present at Nareit REITweek 2024 Investor Conference
GlobeNewswire 05-22 Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire 05-20 Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...
GlobeNewswire 05-16 Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits
GlobeNewswire 05-16 First Wave BioPharma Changes Name to Entero Therapeutics
GlobeNewswire 05-16 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 05-15 FibroBiologics Announces 2024 Annual Meeting of Stockholders
Newsfile Corp 05-15 King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...
GlobeNewswire 05-14 FibroBiologics Files 2024 First Quarter Report